Development & Validation of Pregnancy Specific Pelvic Floor Rehab Protocol
Launched by RIPHAH INTERNATIONAL UNIVERSITY · Mar 9, 2025
Trial Information
Current as of June 26, 2025
Enrolling by invitation
Keywords
ClinConnect Summary
The review of existing literature undergoes the critical need for a pregnancy-specific pelvic floor rehab protocol to address the unique physiological and functional changes experienced during and after pregnancy. While current pelvic floor rehab approaches provide valuable insights, they often lack specific adaptations for the pregnant population, In First Phase of Study the protocol will be developed .The protocol will focus on preventing and managing pelvic floor dysfunction (PFD), such as urinary incontinence, pelvic organ prolapse, and pelvic pain, which are common during pregnancy. Th...
Gender
FEMALE
Eligibility criteria
- Inclusion Criteria:
- • diagnosed pelvic floor dysfunction. Female participants experience pelvic floor symptoms such as incontinence, pelvic pain, or prolapse.
- • No previous participation in a structured pelvic floor rehabilitation program within the last six months
- Exclusion Criteria:
- • Pregnant women or those planning to become pregnant during the study period.
- • Patients with neurological disorders affecting pelvic floor function (e.g., multiple sclerosis, spinal cord injury).
- • Individuals with severe psychiatric conditions that might interfere with participation.
- • Recent pelvic surgery within the last three months.
- • Any contraindications to physical therapy or specific exercises included in the rehab program.
About Riphah International University
Riphah International University is a leading educational institution based in Pakistan, dedicated to advancing healthcare and medical research through innovative clinical trials. With a commitment to excellence in research and education, Riphah emphasizes ethical standards and scientific integrity in its clinical studies. The university collaborates with various stakeholders, including healthcare professionals and industry partners, to enhance patient outcomes and contribute to the global body of medical knowledge. Through its robust research programs, Riphah International University aims to foster a culture of inquiry and improve healthcare delivery both locally and internationally.
Contacts
Jennifer Cobb
Immunology at National Institute of Allergy and Infectious Diseases (NIAID)
Locations
Mansehra, Kpk, Pakistan
Patients applied
Trial Officials
Zahra Ejaz
Principal Investigator
Riphah International University
Timeline
First submit
Trial launched
Trial updated
Estimated completion
Not reported